Document: Guideline on core SmPC for human normal immunoglobulin for subcutaneous and intramuscular administration (SCIg/IMIg)-2025/6/4

Document: Draft guideline on the clinical investigation of human normal immunoglobulin for subcutaneous and/or intramuscular administration (SCIg/IMIg) - Revision 2-2025/6/4

Document: Minutes of the PRAC meeting 07-10 April 2025-2025/6/4

Document: Agenda - Workshop on the use of Bayesian statistics in clinical development-2025/6/4

Document: ICH E21 Guideline on inclusion of pregnant and breastfeeding individuals in clinical trials-2025/6/4

Page: Patients and consumers-2025/6/3

Document: Questions and answers on the refusal of the marketing authorisation for Atropine sulfate FGK (atropine sulfate)-2025/6/3

Page: Quality of medicines questions and answers: Part 2-2025/6/3

Document: European Medicines Agency decision CW/0001/2025 of 2 June 2025 on class waivers in accordance with Regulation EC No 1901-2006 of the European Parliament and of the Council-2025/6/3

Page: Class waivers-2025/6/3